Immunomodulation of allergic responses by targeting costimulatory molecules

Curr Opin Allergy Clin Immunol. 2006 Dec;6(6):489-94. doi: 10.1097/01.all.0000246624.79988.5b.

Abstract

Purpose of review: This review focuses on putative targets, including costimulatory and additional pathways involving T regulatory cells, that may be critical for modifying allergic responses.

Recent findings: Multiple costimulatory signals including CD28/CTLA4: CD80/CD86, ICOS: ICOSL, OX40:OX40L and PD-1: PD-L1/PD-L2 have been identified and implicated in the regulation of immune disorders. Recent studies indicate that T regulatory cells may also suppress T cell costimulation by the secretion of TGF-beta and IL-10, suggesting an important role of T regulatory cells in the regulation of allergic disorders.

Summary: Immune-mediated disorders, including allergic diseases, have been increasing in prevalence. Unravelling these immune pathways may suggest new targets for immunomodulation.

Publication types

  • Review

MeSH terms

  • Animals
  • Antigens, Differentiation / immunology*
  • Humans
  • Hypersensitivity / epidemiology
  • Hypersensitivity / immunology*
  • Hypersensitivity / therapy
  • Immunologic Factors / immunology
  • Immunologic Factors / therapeutic use
  • Prevalence
  • Receptors, Immunologic / agonists
  • Receptors, Immunologic / immunology*
  • T-Lymphocytes, Regulatory / immunology*

Substances

  • Antigens, Differentiation
  • Immunologic Factors
  • Receptors, Immunologic